Chronic Leukemia

20 registered clinical trials studyying Chronic Leukemia — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Feasibility of a Multi-omics Platform for Hematological Malignancies NCT07445438	Azienda Ospedaliero-Universitaria di Parma	N/A
Recruiting	INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE NCT07403630	Azienda Ospedaliero-Universitaria di Parma	N/A
Completed	Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study NCT06063603	Mayo Clinic	N/A
Recruiting	LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study NCT05645510	University of Alberta	—
Recruiting	Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984	Azienda Ospedaliero-Universitaria di Parma	N/A
Unknown	Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance NCT04965649	Centre Hospitalier Universitaire de Nīmes	—
Terminated	Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant NCT03588936	Medical College of Wisconsin	Phase 1
Completed	Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogen NCT02842333	Centre Hospitalier Universitaire de Besancon	N/A
Recruiting	Umbilical Cord Blood Transplantation From Unrelated Donors NCT03016806	University of Rochester	—
Completed	Nonmyeloablative Haploidentical Transplant Followed by MLN9708 NCT02169791	Northside Hospital, Inc.	Phase 2
Terminated	Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor NCT01598025	Memorial Sloan Kettering Cancer Center	N/A
Terminated	Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells NCT01624701	Singapore General Hospital	Phase 1 / Phase 2
Unknown	Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation NCT01472055	Seoul National University Hospital	Phase 2
Completed	Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases NCT01336712	Northside Hospital, Inc.	Phase 2
Completed	Fungemia in Hematologic Malignancies NCT02451592	Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne	—
Unknown	Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT01800643	Hospital Israelita Albert Einstein	Phase 2 / Phase 3
Completed	Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off- NCT01362985	Genzyme, a Sanofi Company	—
Completed	Trial of AVN-944 in Patients With Advanced Hematologic Malignancies NCT00273936	Vertex Pharmaceuticals Incorporated	Phase 1
Completed	Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia NCT00230282	Steven E. Coutre	Phase 2
Active Not Recruiting	Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukem NCT00899223	Alliance for Clinical Trials in Oncology	—